209 related articles for article (PubMed ID: 37459093)
1. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
[TBL] [Abstract][Full Text] [Related]
3. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
4. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
6. Margin Assessment Methods in Oral Cavity Squamous Cell Carcinoma and Recurrence: Tumor Bed vs Resection Specimen Sampling.
Wu SS; Woody N; Hesse J; Cook S; Cracolici V; Ku JA; Prendes B; Silver N; Scharpf J; Brauer PR; Reddy CA; Campbell SR; Koyfman SA; Burkey B; Lamarre ED
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1011-1020. PubMed ID: 37768650
[TBL] [Abstract][Full Text] [Related]
7. Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.
Tang AL; O'Neil T; McDermott S; Tripathi S; Tikhtman R; Mark JR; Patil Y; Tabangin M; Altaye M; Wise-Draper TM; Zender CA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):935-939. PubMed ID: 36006622
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
[TBL] [Abstract][Full Text] [Related]
9. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
[TBL] [Abstract][Full Text] [Related]
10. Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma.
Carey RM; Anagnos VJ; Prasad A; Sangal NR; Rajasekaran K; Shanti RM; Cannady SB; Newman JG; Brant JA; Brody RM
ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):348-359. PubMed ID: 37967536
[TBL] [Abstract][Full Text] [Related]
11. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
[TBL] [Abstract][Full Text] [Related]
13. Re-examining predictors of pathologic lymph node positivity in clinically node negative oral cavity cancer.
Anderson EM; Luu M; Chung EM; Gay C; Mallen-St Clair J; Ho AS; Zumsteg ZS
Oral Oncol; 2023 Sep; 144():106490. PubMed ID: 37413770
[TBL] [Abstract][Full Text] [Related]
14. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
[TBL] [Abstract][Full Text] [Related]
15. Subcategorization of Perineural Invasion Stratifies Oral Cavity Squamous Cell Carcinoma Prognosis.
Fung N; Fleseriu CM; Harley RJ; Khan NI; Kim S
Laryngoscope; 2024 Apr; 134(4):1656-1662. PubMed ID: 37772957
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Distant Metastasis in Patients with Oral Cavity Squamous Cell Carcinoma Undergoing Surgical Treatment.
Aires FT; Lin CS; Matos LL; Kulcsar MAV; Cernea CR
ORL J Otorhinolaryngol Relat Spec; 2017; 79(6):347-355. PubMed ID: 29393250
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.
George JR; Yom SS; Wang SJ
Laryngoscope; 2014 Jul; 124(7):1603-8. PubMed ID: 24318221
[TBL] [Abstract][Full Text] [Related]
19. Significance of Worst Pattern of Invasion-5 in Early-Stage Oral Cavity Squamous Cell Carcinoma.
Mohamed S; Jawad H; Sullivan RO; Callanan D; Sheahan P; Feeley L
Head Neck Pathol; 2023 Sep; 17(3):679-687. PubMed ID: 37486537
[TBL] [Abstract][Full Text] [Related]
20. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
